Belcher Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BELCHER, and what generic and branded alternatives to BELCHER drugs are available?
BELCHER has eighteen approved drugs.
Summary for Belcher
| US Patents: | 0 |
| Tradenames: | 14 |
| Ingredients: | 14 |
| NDAs: | 18 |
| Patent Litigation for Belcher: | See patent lawsuits for Belcher |
Drugs and US Patents for Belcher
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belcher | ESOMEPRAZOLE STRONTIUM | esomeprazole strontium | CAPSULE, DELAYED RELEASE;ORAL | 202342-002 | Aug 6, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Belcher | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 205727-001 | Feb 23, 2016 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Belcher Pharms | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 061602-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Belcher | POTASSIUM CHLORIDE | potassium chloride | FOR SOLUTION;ORAL | 212183-001 | May 6, 2019 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Belcher | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 206651-002 | Nov 30, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Belcher Pharms | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 061602-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
